Use of pretreatment metabolic tumor volumes on PET-CT to predict the survival of patients with squamous cell carcinoma of esophagus treated by curative surgery

Anticancer Research

Volumn 32, Issue 9, 2012, Pages 4163-4168

  Shum, Weng Yoon ^a   Ding, Hueisch Jy ^b   Liang, Ji An ^c,d   Yen, Kuo Yang ^c   Chen, Shang Wen ^c,d   Kao, Chia Hung ^c,d  

^a JEN AI HOSPITAL   (Taiwan)

^b I SHOU UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

2 Fluoro 2 deoxy D glucose (FDG); Esophageal squamous cell carcinoma; Metabolic tumor volume (MTV); Positron emission tomography computed tomography (PET CT)

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DISEASE FREE SURVIVAL; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; FOLLOW UP; HUMAN; MALE; METABOLIC TUMOR VOLUME; OVERALL SURVIVAL; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME; TUMOR VOLUME;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84866990694     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Hong TS, Crowley EM, Killoran J and Mamon HJ: Considerations in treatment planning for esophageal cancer. Semin Radiat Oncol 17: 53-61, 2007.
2. Kaifi JT, Gusani NJ, Jiang Y, Mackley HB, Dye CE, Mathew A, Kimchi ET, Reed MF and Staveley-O'Carroll KF: Multidisciplinary management of early and locally advanced esophageal cancer. J Clin Gastroenterol 45: 391-399, 2011.
3. Pantling AZ, Gossage JA, Mamidanna R, Newman G, Robinson A, Manifold DK and Hale PC: Outcomes from chemoradiotherapy for patients with esophageal cancer. Dis Esophagus 24: 172-176, 2011.
4. Wang BY, Goan YG, Hsu PK, Hsu WH and Wu YC: Tumor length as a prognostic factor in esophageal squamous cell carcinoma. Ann Thorac Surg 91(3): 887-893, 2011.
5. Zhang HL, Chen LQ, Liu RL, Shi YT, He M, Meng XL, Bai SX and Ping YM: The number of lymph node metastases influences survival and International Union Against Cancer tumor-node-metastasis classification for esophageal squamous cell carcinoma. Dis Esophagus 23(1): 53-58, 2010.
6. Rizk N, Venkatraman E, Park B, Flores R, Bains MS and Rusch V: The prognostic importance of the number of involved lymph nodes in esophageal cancer: implications for revisions of the American Joint Committee on Cancer staging system. J Thorac Cardiovasc Surg 132: 1374-1381, 2006.
7. Yuan S, Yu Y, Chao KS, Fu Z, Yin Y, Liu T, Chen S, Yang X, Yang G, Guo H and Yu J: Additional value of PET/CT over PET in assessment of locoregional lymph nodes in thoracic esophageal squamous cell cancer. J Nucl Med 47: 1255-1259, 2006.
8. 18F-FDG PET in patients with esophageal squamous cell carcinoma undergoing curative surgery: prognostic implications. J Nucl Med 45: 1843-50, 2004.
9. Omloo JMT, van Heijl M, Hoekstra OS, van Berge Henegouwen MI, van Lanschot JJB and Sloof GW: FDG-PET parameters as prognostic factor in esophageal cancer patients: A review. Ann Surg Oncol 18: 3338-3352, 2011.
10. Cerfolio RJ and Bryant AS: Maximum standardized uptake values on positron emission tomography of esophageal cancer predicts stage, tumor biology, and survival. Ann Thorac Surg 82: 391-394, 2006.
11. 18F]-fluorodeoxyglucose positron emission tomography/computed tomography predicts short-term outcome to radiotherapy with or without chemotherapy in pharyngeal cancer. Clin Cancer Res 15: 5861-5868, 2009.
12. Seol YM, Kwon BR, Song MK, Choi YJ, Shin HJ, Chung JS, Cho GJ, Lee JC, Lee BJ, Wang SG, Kim HJ, Kim WT, Kim SJ and Yun EY: Measurement of tumor volume by PET to evaluate prognosis in patients with head and neck cancer treated by chemo-radiation therapy. Acta Oncol 49: 201-208, 2010.
13. La TH, Filion EJ, Turnbull BB, Chu JN, Lee P, Nguyen K, Maxim P, Quon A, Graves EE, Loo BW Jr. and Le QT: Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer. Int J Radiat Oncol Biol Phys 74: 1335-1341, 2009.
14. 18F- Fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma. Ann Surg Oncol 17: 115-122, 2010.
15. Shum WY, Hsieh TC, Yeh JJ, Chen JH, Su CC, Liang JA and Kao CH: Clinical usefulness of dual-time FDG PET-CT in assessment of esophageal squamous cell carcinoma. Eur J Radiol 81(5): 1024-1028, 2012.
16. 18F-FDG PET/CT on gross tumor volume delineation for radiotherapy planning in esophageal squamous cell carcinoma. J Radiat Res (Epub ahead of print)
17. Minn H, Clavo AC, Grenman R and Wahl RL: In vitro comparison of cell proliferation kinetics and uptake of tritiated fluorodeoxyglucose and L-methionine in squamous-cell carcinoma of the head and neck. J Nucl Med 36: 252-258, 1995.
18. Clavo AC, Brown RS and Wahl RL: Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia. J Nucl Med 36: 1625-1632, 1995.
19. Furuta M, Hasegawa M, Hayakawa K, Yamakawa M, Ishikawa H, Nonaka T, Mitsuhashi N and Niibe H: Rapid rise in FDG uptake in an irradiated human tumour xenograft. Eur J Nucl Med 24: 435-438, 1997.
20. Kato H, Kuwano H, Nakajima M, Miyazaki T, Yoshikawa M, Ojima H, Tsukada K, Oriuchi N, Inoue T and Endo K: Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma. Cancer 94: 921-928, 2002.
21. Hsu WH, Hsu PK, Wang SJ, Lin KH, Huang CS, Hsieh CC and Wu YC: Positron emission tomography-computed tomography in predicting locoregional invasion in esophageal squamous cell carcinoma. Ann Thorac Surg 87: 1564-1568, 2009.